This website uses cookies

Read our Privacy policy and Terms of use for more information.

“We believe that by assessing patients through mental health screening and influencing individualized care through recovery capital measurements, patient’s risk for relapse in opioid treatment programs can be reduced despite COVID-19, says Saadi.